Accrued Expenses

9 Months Ended

Mar. 31, 2018

6.	Accrued Expenses

Accrued expenses consisted of the following at March 31, 2018 and June 30, 2017 (in thousands):


	March 31, 2018		June 30, 2017
Clinical trial costs	$	722	$	1,984
Personnel costs		1,144		1,632
Professional fees		1,282		590
Other		67		18

	$	3,215	$	4,224

In January 2017, the Company entered into retention bonus agreements with five employees. Under these agreements (a) cash payments totaling $319,000 were made on December 22, 2017 and (b) subject to continuing employment, a total of 305,616 restricted stock units (“RSUs”) of an equal value were granted at that date based on a closing share price of $1.045 per share with a one-year vesting period. Included in personnel costs in the above table were $0 and $160,000 at March 31, 2018 and June 30, 2017, respectively, representing pro rata accrual of the cash bonus component.

At March 31, 2018, approximately $858,000 of accrued professional fees were directly attributable to services rendered in the Icon Acquisition, the Equity Transactions (as defined in Note 9) and the transactions contemplated by the Credit Agreement (as defined in Note 8).